| Hilary Verson, RN MS FNP | |
|
455 East South Temple, #202, Slc, UT 84111-1325 | |
| (801) 355-9951 | |
| (801) 355-9968 |
| Full Name | Hilary Verson |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 455 East South Temple, Slc, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003119819 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 212581-4405 (Utah) | Primary |
| Entity Name | University Of Utah Adult Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
Manhattan Pharmaceuticals, Inc. announced preliminary results today from a Phase 1/2 study of AST-915 for the treatment of essential tremor. Data from this single dose study demonstrated that AST-915 was safe and well tolerated and demonstrated a clear effect on tremor power.
In response to increasing public enquiries for information on respiratory allergies, the Asthma Society of Canada announced today the launch of Allergies Count Too, NOW a program that will fill the gap in allergy education and provide critical information to Canadians.
Most patients with an inherited heart condition known as arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) don't know they have a problem until they're in their early 20s. The lack of symptoms at younger ages makes it very difficult for researchers to study how ARVD/C evolves or to develop treatments. A new stem cell-based technology created by 2012 Nobel Prize winner Shinya Yamanaka, M.D., Ph.D., helps solve this problem.
Roboticists at the University of California San Diego have developed an affordable, easy to use a system to track the location of flexible surgical robots inside the human body.
Research ethics review committees often require all women of childbearing age who enroll in clinical trials to use contraceptives to protect against a developing fetus being exposed to potentially harmful drugs. A mandatory contraceptive policy is often imposed even when there is no evidence that a trial drug could harm a fetus or when women have no chance of becoming pregnancy. This requirement is excessive and can safely be relaxed in many cases, according to a report in IRB: Ethics & Human Research.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hilary Verson, RN MS FNP 455 East South Temple, #202, Slc, UT 84111-1325 Ph: (801) 355-9951 | Hilary Verson, RN MS FNP 455 East South Temple, #202, Slc, UT 84111-1325 Ph: (801) 355-9951 |
News Archive
Manhattan Pharmaceuticals, Inc. announced preliminary results today from a Phase 1/2 study of AST-915 for the treatment of essential tremor. Data from this single dose study demonstrated that AST-915 was safe and well tolerated and demonstrated a clear effect on tremor power.
In response to increasing public enquiries for information on respiratory allergies, the Asthma Society of Canada announced today the launch of Allergies Count Too, NOW a program that will fill the gap in allergy education and provide critical information to Canadians.
Most patients with an inherited heart condition known as arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) don't know they have a problem until they're in their early 20s. The lack of symptoms at younger ages makes it very difficult for researchers to study how ARVD/C evolves or to develop treatments. A new stem cell-based technology created by 2012 Nobel Prize winner Shinya Yamanaka, M.D., Ph.D., helps solve this problem.
Roboticists at the University of California San Diego have developed an affordable, easy to use a system to track the location of flexible surgical robots inside the human body.
Research ethics review committees often require all women of childbearing age who enroll in clinical trials to use contraceptives to protect against a developing fetus being exposed to potentially harmful drugs. A mandatory contraceptive policy is often imposed even when there is no evidence that a trial drug could harm a fetus or when women have no chance of becoming pregnancy. This requirement is excessive and can safely be relaxed in many cases, according to a report in IRB: Ethics & Human Research.
› Verified 7 days ago
Miss Danielle Sue Wright, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 344 E 100 S Ste 301, Slc, UT 84111 Phone: 801-428-4257 |